Financhill
Buy
51

REPL Quote, Financials, Valuation and Earnings

Last price:
$10.10
Seasonality move :
-19.36%
Day range:
$9.84 - $10.27
52-week range:
$2.68 - $14.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.01x
Volume:
607.1K
Avg. volume:
1.7M
1-year change:
-19.28%
Market cap:
$791.5M
Revenue:
--
EPS (TTM):
-$3.61

Earnings Data

Next earnings date for REPL
Feb 12
2026
Most recent earnings per share
-$0.90
Missed by $0.11
(Nov 6/2025)
Consensus Estimate
-$0.79
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

REPL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/12/2026 Q4 -- -- -- -$0.82 --
11/06/2025 Q3 $500K -- -$0.90 -$0.79 -$0.11
08/08/2025 Q2 -- -- -$0.95 -$0.80 -$0.15
05/22/2025 Q1 -- -- -$0.96 -$0.69 -$0.27
02/12/2025 Q4 -- -- -$0.79 -$0.72 -$0.07
11/12/2024 Q3 -- -- -$0.68 -$0.74 $0.06
08/08/2024 Q2 -- -- -$0.78 -$0.84 $0.06
05/16/2024 Q1 -- -- -$0.90 -$0.80 -$0.10
02/08/2024 Q4 -- -- -$0.77 -$0.94 $0.17
11/07/2023 Q3 -- -- -$0.90 -- --
08/03/2023 Q2 -- -- -$0.75 -- --
05/18/2023 Q1 -- -- -$0.87 -- --
02/09/2023 Q4 -- -- -$0.69 -- --
11/03/2022 Q3 -- -- -$0.79 -- --
08/04/2022 Q2 -- -- -$0.78 -- --
05/19/2022 Q1 -- -- -$0.67 -- --
02/03/2022 Q4 -- -- -$0.57 -- --
11/04/2021 Q3 -- -- -$0.56 -- --
08/06/2021 Q2 -- -- -$0.53 -- --
05/20/2021 Q1 -- -- -$0.46 -- --
02/04/2021 Q4 -- -- -$0.44 -- --
11/05/2020 Q3 -- -- -$0.46 -- --
08/07/2020 Q2 -- -- -$0.44 -- --
06/03/2020 Q1 -- -- -$0.43 -- --
02/13/2020 Q4 -- -- -$0.46 -- --
11/11/2019 Q3 -- -- -$0.35 -- --
08/14/2019 Q2 -- -- -$0.30 -- --
06/28/2019 Q1 -- -- -$0.21 -- --
02/14/2019 Q4 -- -- -$0.24 -- --
11/14/2018 Q3 -- -- -$0.26 -- --
08/30/2018 Q2 -- -- -$0.32 -- --
03/31/2018 Q1 -- -- -$0.22 -- --
12/31/2017 Q4 -- -- -$0.14 -- --
09/30/2017 Q3 -- -- -$0.15 -- --
06/30/2017 Q2 -- -- -$0.11 -- --
03/31/2017 Q1 -- -- -$0.12 -- --

Replimune Group, Inc. Earnings Questions

  • How Much did Replimune Group, Inc. Generate in Revenue Last Quarter?

    Replimune Group, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Replimune Group, Inc. Beat Earnings Last Quarter?

    Replimune Group, Inc. announced earnings per share of -$0.90 which represents a miss of analyst forecast a -$0.79 per share.

  • Is Replimune Group, Inc. Profitable?

    Replimune Group, Inc. reported -$1.6M that represents -$0.02 per share over the last quarter.

  • What is the Analyst Consensus for Replimune Group, Inc. EPS Next Year?

    Replimune Group, Inc.'s earnings are forecast to decrease from -$3.07 per share to -$2.81 per share next year representing a decrease of -9.72%.

  • When is Replimune Group, Inc.'s Earnings Date?

    Replimune Group, Inc.'s next earnings date is February 12, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock